<DOC>
	<DOCNO>NCT01351883</DOCNO>
	<brief_summary>Perioperative usage immunonutrition ( ANOM® ) attenuate pro-inflammatory cytokine reduce postoperative infectious complication length hospital stay major upper gastrointestinal surgery . ( ANOM® ) immunonutrition product name</brief_summary>
	<brief_title>Enteric Immune-nutrition Formula ( ANOM® ) Patients Receiving Major Upper Gastrointestinal Surgery</brief_title>
	<detailed_description>Background : Perioperative usage immunonutrition attenuate pro-inflammatory cytokine reduce postoperative infectious complication length hospital stay major upper gastrointestinal surgery . The aim study elucidate effect immunomodulating diet , ANOM® , surgical outcome elective major upper gastrointestinal tract operation . Material Methods : Design : Prospective , randomize , control trial . Participants : Seventy upper gastrointestinal tract cancer patient plan undergo major upper gastrointestinal surgery eesophagus、stomach、pancreas duodenum , Interventions : Patients divide randomly two group receive ANOM® standard diet . Before surgery , 800ml ANOM® standard diet ( SEN ) give 5 day mouth . After operation , 5 % Distill water ( D5W ) combine ANOM® standard diet since 2nd post-operation day ( POD2 ) day 14 ( POD14 ) discharge day enteric route use nasogastric tube ( NG ) tube jejunostomy . Postoperative parenteral nutrition give maintain adequate nutrition . Clinical Assessment : The preoperative postoperative immunological parameter , infection complication , hospital stay compare .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<criteria>1 . Age range 18 80 year old 2 . Patients upper gastrointestinal disease , plan receive elective major upper gastrointestinal tract surgery , subtotal gastrectomy , proximal gastrectomy , total gastrectomy , esophagectomy , pancreatectomy , pancreaticoduodenectomy , duodenectomy , etc . 3 . Patient able understand requirement study sign Informed Consent Form . 1 . Patient severe malnutrition condition , albumin &lt; 2.6mg/ml 2 . Patient severe pulmonary , cardiovascular , renal hepatic disease 3 . Patient immunosuppressive therapy immunological disease recently 4 . Patient ongoing infection condition 5 . Patient emergency operation 6 . Patient widespread metastatic disease surgery 7 . Patient bowel obstruction disease 8 . Investigator judge subject inappropriate clinical study ( e.g. , patient severe complication )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>immunomodulating diet</keyword>
	<keyword>postoperative infection</keyword>
</DOC>